Search Results - "Patel, Ami V."
-
1
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation
Published in Cell reports (Cambridge) (01-03-2016)“…To identify genes and signaling pathways that initiate Neurofibromatosis type 1 (NF1) neurofibromas, we used unbiased insertional mutagenesis screening, mouse…”
Get full text
Journal Article -
2
BDNF is required for the survival of differentiated geniculate ganglion neurons
Published in Developmental biology (15-04-2010)“…In mice lacking functional brain-derived neurotrophic factor (BDNF), the number of geniculate ganglion neurons, which innervate taste buds, is reduced by…”
Get full text
Journal Article -
3
Neurotrophin-4 regulates the survival of gustatory neurons earlier in development using a different mechanism than brain-derived neurotrophic factor
Published in Developmental biology (01-05-2012)“…The number of neurons in the geniculate ganglion that are available to innervate taste buds is regulated by neurotrophin-4 (NT-4) and brain-derived…”
Get full text
Journal Article -
4
Fatty acid synthase is a metabolic oncogene targetable in malignant peripheral nerve sheath tumors
Published in Neuro-oncology (Charlottesville, Va.) (01-12-2015)“…Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas with minimal therapeutic opportunities. We observed that lipid droplets (LDs)…”
Get full text
Journal Article -
5
Lingual and palatal gustatory afferents each depend on both BDNF and NT-4, but the dependence is greater for lingual than palatal afferents
Published in Journal of comparative neurology (1911) (15-08-2010)“…Neurons of the geniculate ganglion innervate taste buds located in two spatially distinct targets, the tongue and palate. About 50% of these neurons die in…”
Get full text
Journal Article -
6
An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors
Published in EBioMedicine (01-07-2016)“…Malignant peripheral nerve sheath tumors (MPNST) are rare soft tissue sarcomas that are a major source of mortality in neurofibromatosis type 1 (NF1) patients…”
Get full text
Journal Article -
7
Providing Palliative Care to Patients Throughout the State of Indiana from a Centralized Virtual Palliative Care Hub
Published in Joint Commission journal on quality and patient safety (01-12-2022)“…Access to palliative care clinicians is a limited resource. Expanding the reach of existing palliative care expertise by utilizing virtual care is one strategy…”
Get full text
Journal Article -
8
Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST
Published in Cancer research (Chicago, Ill.) (01-11-2020)“…Plexiform neurofibromas are benign nerve sheath Schwann cell tumors characterized by biallelic mutations in the neurofibromatosis type 1 (NF1) tumor suppressor…”
Get full text
Journal Article -
9
Ras-Driven Transcriptome Analysis Identifies Aurora Kinase A as a Potential Malignant Peripheral Nerve Sheath Tumor Therapeutic Target
Published in Clinical cancer research (15-09-2012)“…Patients with neurofibromatosis type 1 (NF1) develop malignant peripheral nerve sheath tumors (MPNST), which are often inoperable and do not respond well to…”
Get full text
Journal Article -
10
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation
Published in Oncotarget (14-03-2017)“…Malignant peripheral nerve sheath tumor (MPNST) and neuroblastoma models respond to the investigational small molecule Aurora A kinase inhibitor, alisertib. We…”
Get full text
Journal Article -
11
CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin
Published in Oncotarget (16-08-2016)“…Malignant peripheral nerve sheath tumors (MPNSTs) are soft tissue sarcomas that are a major cause of mortality of Neurofibromatosis type 1 (NF1) patients…”
Get full text
Journal Article -
12
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomas
Published in American journal of cancer research (01-01-2020)“…Neurofibromatosis type 1 (NF1) and Neurofibromatosis type 2 (NF2) are two dominantly inherited disorders that cause tumors in Schwann cells. NF1 patients have…”
Get full text
Journal Article -
13
Care of Patients at the End of Life: Surrogate Decision Making for Incapacitated Patients
Published in FP essentials (Online) (01-08-2016)“…Competence is determined by a court of law, whereas physicians determine medical decision-making capacity (DMC). When patients lack DMC, a surrogate should be…”
Get more information
Journal Article -
14
Discovery of a small molecule targeting IRA2 deletion in budding yeast and neurofibromin loss in malignant peripheral nerve sheath tumor cells
Published in Molecular cancer therapeutics (01-09-2011)“…Malignant peripheral nerve sheath tumor (MPNST) is a life-threatening complication of neurofibromatosis type 1 (NF1). NF1 is caused by mutation in the gene…”
Get full text
Journal Article -
15
EGFR–STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors
Published in Oncogene (09-01-2014)“…Malignant peripheral nerve sheath tumors (MPNSTs) develop sporadically or in the context of neurofibromatosis type 1. Epidermal growth factor receptor (EGFR)…”
Get full text
Journal Article -
16
BDNF and NT-4 each employ distinct mechanisms to regulate development of the geniculate ganglion
Published 01-01-2009“…Neurons of the geniculate ganglion innervate taste buds located in the tongue and the palate. About 50% of these neurons die in bdnf -/- as well as nt-4-/-…”
Get full text
Dissertation -
17
BDNF and NT-4 each employ distinct mechanisms to regulate development of the geniculate ganglion
Get full text
Dissertation